Although GPER can be expressed on multiple cell types which impact ER+ disease, including ER+ tumor cells themselves, CAFs, endothelial cells, and immune subpopulations, its role in breast cancer is not well-understood [189,190,191]. This evidence concerns the gene ESR1 and neoplasm.